Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.645,52
0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Precision BioSciences Inc (DTIL) Precision BioSciences Inc (DTIL) Notizie

Precision BioSciences Inc

DTIL
9,70
-0,02 (-0,21%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202422:15BWPrecision BioSciences Announces Return of Programs and..
27/3/202411:45BWPrecision BioSciences Reports Fourth Quarter and Fiscal Year..
20/3/202421:30BWPrecision BioSciences to Report Fourth Quarter and Fiscal..
19/3/202412:00BWPrecision BioSciences Presents Preclinical Data Highlighting..
06/3/202414:45BWPrecision BioSciences Announces MHRA Approval for Partner..
01/3/202414:00EDGAR2Form 8-K - Current report
01/3/202412:30BWPrecision BioSciences Announces $40.0 Million Offering of..
01/3/202412:00EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/2/202423:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:01BWPrecision BioSciences Announces Proposed Public Offering of..
20/2/202413:00BWPrecision BioSciences Announces Non-Exclusive Patent License..
14/2/202413:00BWPrecision BioSciences Receives Pre-IND Feedback from US FDA..
13/2/202414:29EDGAR2Form 8-K - Current report
13/2/202413:00BWPrecision BioSciences Promotes Naresh Tanna to Vice..
12/2/202417:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202413:00BWPrecision BioSciences Receives Initial $7.5 Million Cash..
09/2/202413:00BWPrecision BioSciences to Effect a Reverse Stock Split
24/1/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:29EDGAR2Form 8-K - Current report
23/1/202422:27EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:46EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:42EDGAR2Form 144 - Report of proposed sale of securities
22/1/202421:42EDGAR2Form 144 - Report of proposed sale of securities
19/1/202413:30EDGAR2Form 8-K - Current report
12/1/202414:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/1/202414:31EDGAR2Form 8-K - Current report
09/1/202415:20APSBiotech Massively Bid Up Before Opening Bell
09/1/202413:00BWPrecision BioSciences Completes License Deal with TG..
22/12/202314:12EDGAR2Form 8-K - Current report
13/12/202314:20BWPrecision BioSciences Announces Approval of First Clinical..
04/12/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/12/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202313:00BWPrecision BioSciences Announces Publication in Nature..
30/11/202313:00BWPrecision BioSciences to Present at Hep-DART 2023
28/11/202313:00BWPrecision BioSciences Announces Grant of Inducement Award..
13/11/202313:05BWPrecision BioSciences Presents Late-Breaking Data..
10/11/202313:00BWPrecision BioSciences to Present at Upcoming Sidoti..
09/11/202313:00BWPrecision BioSciences Announces Late-Breaking Poster..
07/11/202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:15EDGAR2Form 8-K - Current report
07/11/202313:00BWPrecision BioSciences Reports Third Quarter 2023 Financial..
06/11/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202320:46EDGAR2Form 144 - Report of proposed sale of securities
03/11/202320:44EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 9,65 Min: 9,38 Max: 10,00
Chiusura: 9,72

La tua Cronologia

NASDAQ
DTIL
Precision BioSciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network